With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Epigenetic regulation of genomic instability and its therapeutic implications in T-cell acute lymphoblastic leukemia||Dana-Farber Cancer Institute / Birgit Knoechel, MD/PhD||Innovation Grants||2019||Massachusetts|
|CD36-Sphingosine 1-Phosphate Axis in Osteosarcoma Progression||Medical University of South Carolina / Meenal Mehrotra, MD/PhD||Innovation Grants||2019||South Carolina|
|The use of hematopoietic stem and progenitor cells to reverse treatment resistance to PD-1 blockade||University of Florida / Catherine Flores, PhD||Innovation Grants||2019||Florida|
|Targeting mechanisms of Siglec15-mediated immune evasion in hematologic malignancies||Emory University / Christopher Porter, MD||Innovation Grants||2019||Georgia|
|Norepinephrine Transporter-Targeted Pharmacotherapy of Aggressive Neuroblastoma||Children’s Hospital of Philadelphia / Michael Chorny, PhD||Innovation Grants||2019||Pennsylvania|
|Pediatric Osteosarcoma: Identifying the elusive molecular signature and its relationship to this disease||St. Jude Children’s Research Hospital / Linda Hendershot, PhD||Innovation Grants||2019||Tennessee|
|Predicting and Overcoming Resistance to Immunotherapy in Pediatric High-Grade Glioma||Ann & Robert H. Lurie Children’s Hospital of Chicago / Oren Becher, MD & Robert Wechsler-Reya, PhD||Innovation Grants||2019||Illinois|
|Targeting symmetric division in pediatric cancers||Dana-Farber Cancer Institute / Rosalind Segal, MD/PhD||Innovation Grants||2019||Massachusetts|
|Developing drugs to treat NT5C2 mediated resistance in pediatric ALL||New York University School of Medicine / William Carroll, MD||Innovation Grants||2019||New York|
|Identify Novel Druggable Targets to Treat Philadelphia chromosome-like B-Acute Lymphoblastic Leukemia||Children’s Hospital of Philadelphia / Wei Tong, PhD||Innovation Grants||2019||Pennsylvania|